• LAST PRICE
    42.2900
  • TODAY'S CHANGE (%)
    Trending Down-1.2000 (-2.7593%)
  • Bid / Lots
    41.5200/ 1
  • Ask / Lots
    42.2600/ 1
  • Open / Previous Close
    43.2000 / 43.4900
  • Day Range
    Low 41.3300
    High 43.2900
  • 52 Week Range
    Low 26.6100
    High 75.0167
  • Volume
    249,068
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 43.49
TimeVolumeGPCR
09:32 ET213843.2
09:36 ET10042.42
09:38 ET10043.29
09:41 ET10043
09:45 ET224743.07
09:48 ET207542.7
09:50 ET10042.68
09:52 ET50942.71
09:54 ET90042.93
09:56 ET30042.9
09:57 ET32543.002
09:59 ET30043.1
10:01 ET233043.21
10:03 ET349043.04
10:06 ET20043.04
10:10 ET20042.96
10:12 ET124242.87
10:14 ET136743
10:15 ET180943
10:21 ET1688242.01
10:24 ET327841.86
10:28 ET332541.87
10:30 ET294142.09
10:32 ET61142.105
10:33 ET10042.0001
10:35 ET69442.1257
10:37 ET185041.965
10:39 ET120041.955
10:42 ET50041.94
10:44 ET13541.94
10:46 ET92641.9838
10:48 ET119742.03
10:50 ET80042.13
10:51 ET10042.13
10:55 ET20041.94
10:57 ET103742.0546
11:02 ET86141.97
11:06 ET70041.795
11:08 ET90141.84
11:09 ET20041.7
11:11 ET150041.86
11:13 ET82841.835
11:18 ET42241.83
11:20 ET40041.85
11:24 ET50041.845
11:26 ET30041.8599
11:29 ET40341.9871
11:33 ET10041.95
11:36 ET30041.91
11:38 ET67441.8572
11:40 ET129841.8627
11:42 ET30041.785
11:44 ET57041.89
12:00 ET30041.8166
12:02 ET70041.81
12:03 ET240041.765
12:07 ET190041.8731
12:09 ET48641.855
12:12 ET10041.84
12:14 ET13241.84
12:16 ET101141.85
12:18 ET50041.93
12:20 ET15041.836
12:21 ET327141.82
12:23 ET10041.85
12:25 ET10041.94
12:30 ET68841.905
12:32 ET260042.04
12:34 ET90042.105
12:36 ET79042.16
12:38 ET40042.25
12:39 ET71642.07
12:41 ET80541.9
12:43 ET10841.845
12:45 ET30041.92
12:50 ET43141.57
12:52 ET80041.615
12:54 ET25041.5836
12:56 ET10041.675
12:57 ET37541.4732
12:59 ET10041.565
01:03 ET34441.5716
01:10 ET55041.53
01:12 ET40041.6
01:14 ET40041.53
01:15 ET123641.5
01:17 ET98041.63
01:19 ET10041.56
01:24 ET127141.55
01:26 ET30041.57
01:30 ET110041.545
01:32 ET50041.525
01:33 ET20041.545
01:35 ET10041.5456
01:37 ET110041.5
01:39 ET360041.51
01:42 ET50041.5
01:44 ET80041.52
01:46 ET132541.6
01:48 ET30041.63
01:50 ET33041.655
02:00 ET10841.6
02:02 ET70041.73
02:09 ET40041.7
02:11 ET130041.69
02:13 ET67041.695
02:15 ET60041.7306
02:18 ET64041.79
02:20 ET10841.78
02:22 ET170741.97
02:24 ET10041.95
02:29 ET10041.74
02:31 ET10041.74
02:38 ET60041.7
02:40 ET80041.735
02:42 ET20041.755
02:44 ET36941.7
02:49 ET30341.75
02:58 ET19841.67
03:00 ET170041.865
03:03 ET10041.81
03:05 ET245041.97
03:07 ET10041.945
03:09 ET20641.94
03:14 ET26241.92
03:16 ET50042.01
03:18 ET10042.03
03:21 ET70042.18
03:23 ET40042.19
03:27 ET30442.22
03:30 ET10042.32
03:32 ET25042.32
03:34 ET20042.27
03:36 ET20042.34
03:38 ET424142.355
03:39 ET10042.35
03:41 ET40042.27
03:43 ET90042.35
03:45 ET160142.41
03:48 ET30042.36
03:50 ET22042.39
03:52 ET70042.39
03:54 ET22442.48
03:56 ET147142.345
03:57 ET155542.37
03:59 ET3630842.29
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGPCR
Structure Therapeutics Inc
2.5B
-18.9x
---
United StatesIBRX
Immunitybio Inc
2.5B
-3.6x
---
United StatesCGON
CG Oncology Inc
2.4B
-30.8x
---
United StatesEWTX
Edgewise Therapeutics Inc
2.6B
-17.4x
---
United StatesSWTX
SpringWorks Therapeutics Inc
2.4B
-7.2x
---
United StatesVRNA
Verona Pharma PLC
2.3B
-19.8x
---
As of 2024-10-03

Company Information

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.

Contact Information

Headquarters
611 Gateway Blvd Suite 223SOUTH SAN FRANCISCO, CA, United States 94080
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Daniel Welch
Chief Executive Officer, Director
Raymond Stevens
Chief Financial Officer
Jun Yoon
Chief Technology Officer
Yingli Ma
Chief Scientific Officer
Xichen Lin

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.5B
Revenue (TTM)
$0.00
Shares Outstanding
57.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.24
Book Value
$9.76
P/E Ratio
-18.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.